Goldman Sachs’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.29M | Buy |
|
|||||
|
2025
Q1 | $4.91M | Sell |
|
|||||
|
2024
Q4 | $8.35M | Sell |
|
|||||
|
2024
Q3 | $11.7M | Buy |
|
|||||
|
2024
Q2 | $7.9M | Buy |
|
|||||
|
2024
Q1 | $2.89M | Buy |
|
|||||
|
2023
Q4 | $1.31M | Buy |
|
|||||
|
2023
Q3 | $779K | Sell |
|
|||||
|
2023
Q2 | $1.09M | Sell |
|
|||||
|
2023
Q1 | $1.84M | Buy |
|
|||||
|
2022
Q4 | $1.77M | Sell |
|
|||||
|
2022
Q3 | $4.19M | Buy |
|
|||||
|
2022
Q2 | $2.12M | Buy |
|
|||||
|
2022
Q1 | $876K | Buy |
|
|||||
|
2021
Q4 | $1.24M | Sell |
|
|||||
|
2021
Q3 | $3.56M | Buy |
|
|||||
|
2021
Q2 | $318K | Sell |
|
|||||
|
2021
Q1 | $2.34M | Buy |
|